Endece LLC is a dedicated research and development company based in Mequon, WI, focused on discovering and creating innovative treatments for neurodegenerative diseases. Led by Dr. James Yarger, their team is committed to stopping disease progression, restoring function, and enhancing the quality of life for patients.
With their groundbreaking drug, NDC-1308, Endece offers a unique approach to treating multiple sclerosis (MS) and other neurodegenerative conditions. NDC-1308 has the potential to induce remyelination of demyelinated axons within the central nervous system (CNS) while also protecting the CNS from further demyelination, making it a promising therapeutic option for patients.
Generated from the website